Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Parasite Immunol ; 38(1): 5-11, 2016 Jan.
Article in English | MEDLINE | ID: mdl-26345715

ABSTRACT

Throughout evolution, both helminths and bacteria have inhabited our intestines. As intestinal helminths and bacteria inhabit the same environmental niche, it is likely that these organisms interact with, and impact on, each other. In addition, intestinal helminths are well known to alter intestinal physiology, permeability, mucous secretion and the production of antimicrobial peptides - all of which may impact on bacterial survival and spatial organization. Yet despite rapid advances in our understanding of host-intestinal bacteria interactions, the impact of helminths on this relationship has remained largely unexplored. Moreover, although intestinal helminths are generally accepted to possess potent immuno-modulatory activity, it is unknown whether this capacity requires interactions with intestinal bacteria. We propose that this 'ménage à trois' situation is likely to have exerted a strong selective pressure on the development of our metabolic and immune systems. Whilst such pressures remain in developing countries, the eradication of helminths in industrialized countries has shifted this evolutionary balance, possibly underlying the increased development of chronic inflammatory diseases. Thus, helminth-bacteria interactions may represent a key determinant of healthy homoeostasis.


Subject(s)
Bacteria/immunology , Gastrointestinal Microbiome/immunology , Helminths/immunology , Host-Parasite Interactions/immunology , Intestines/microbiology , Intestines/parasitology , Animals , Bacterial Physiological Phenomena , Gastrointestinal Microbiome/physiology , Helminths/physiology , Humans
2.
Mucosal Immunol ; 6(6): 1157-67, 2013 Nov.
Article in English | MEDLINE | ID: mdl-23515135

ABSTRACT

Thymic stromal lymphopoietin (TSLP) is constitutively expressed in the intestine and is known to regulate inflammation in models of colitis. We show that steady-state TSLP expression requires intestinal bacteria and has an important role in limiting the expansion of colonic T helper type 17 (Th17) cells. Inappropriate expansion of the colonic Th17 cells occurred in response to an entirely benign intestinal microbiota, as determined following the colonization of germ-free C57BL/6 or TSLPR(-/-) mice with the altered Schaedler flora (ASF). TSLP-TSLPR (TSLP receptor) interactions also promoted the expansion of colonic Helios(-)Foxp3(+) regulatory T cells, necessary for the control of inappropriate Th17 responses following ASF bacterial colonization. In summary, these data reveal an important role for TSLP-TSLPR signaling in promoting steady-state mutualistic T-cell responses following intestinal bacterial colonization.


Subject(s)
Bacteria/immunology , Colitis/immunology , Cytokines/metabolism , Intestines/immunology , T-Lymphocytes, Regulatory/immunology , Th17 Cells/immunology , Animals , Cell Communication , Cell Proliferation , Cells, Cultured , Cytokines/genetics , Cytokines/immunology , Forkhead Transcription Factors/metabolism , Humans , Immunity, Cellular , Immunoglobulins/metabolism , Immunomodulation , Intestines/microbiology , Mice , Mice, Inbred C57BL , Mice, Knockout , Microbiota/immunology , Receptors, Cytokine/metabolism , Thymic Stromal Lymphopoietin
3.
Autoimmunity ; 42(4): 346-8, 2009 May.
Article in English | MEDLINE | ID: mdl-19811297

ABSTRACT

Rheumatoid arthritis (RA) displays a chronic inflammatory joint disease, accompanied by symmetric polyarthritis (PA) which evokes synovial inflammation, cartilage damage, and bone erosion. Patients with RA are routinely treated by immunosuppressive drugs. The therapy of inflammatory diseases and degenerative disorders with Low-dose radiotherapy (LD-RT) (single doses from 0.3 to 1.0 Gy) represents a low cost therapy with low toxicity, and is able to substitute at least in part treatment with drugs. The efficiency of LD-RT has already been proven in several animal models of inducible arthritis. In the present study we used a human TNF transgenic mouse model to examine the effects of LD-RT on PA. We observed a significant temporal improvement of the clinical progression of disease when mice were irradiated at the beginning of the disease. These data emphasize the role of LD-RT in clinical settings to treat patients with chronic and degenerative disorders and diseases.


Subject(s)
Arthritis/radiotherapy , Whole-Body Irradiation , Animals , Arthritis/genetics , Arthritis, Experimental/genetics , Arthritis, Experimental/radiotherapy , Disease Models, Animal , Humans , Mice , Mice, Transgenic , Tumor Necrosis Factor-alpha/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...